SCHEMBL659522

SCHEMBL659522

Nc1nccc2cc(-c3cccn4cncc34)oc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
QPCT Q16769 1/20 0.39
QPCTL Q9NXS2 1/20 0.39
TLR8 Q9NR97 2/20 0.38
MAPT P10636 2/20 0.37
CYP17A1 P05093 2/20 0.34
CYP1A2 P05177 1/20 0.34
IDO1 P14902 2/20 0.33
MAP3K7 O43318 4/20 0.32
TAB1 Q15750 4/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
RAB9A P51151 1/20 0.31
PRMT5 O14744 1/20 0.31
WDR77 Q9BQA1 1/20 0.31
SRC P12931 1/20 0.30
TDO2 P48775 1/20 0.30
CDC7 O00311 1/20 0.30
CDK2 P24941 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL661238 0.79 QPCT (0.38) QPCTQPCTLCYP17A1IDO1MAP3K7
SCHEMBL660235 0.72 LMNA (0.44) TLR8MAPTCYP1A2MAP3K7TAB1
SCHEMBL659267 0.71 MAP3K7 (0.49) TLR8MAPTMAP3K7TAB1
SCHEMBL659953 0.70 TLR8 (0.41) TLR8MAPTMAP3K7TAB1KDM4E
SCHEMBL657741 0.68 MAP3K7 (0.45) TLR8MAPTMAP3K7TAB1KDM4E
SCHEMBL659026 0.68 RAB9A (0.58) TLR8MAPTCYP1A2MAP3K7TAB1
SCHEMBL659131 0.67 MAP3K7 (0.44) TLR8MAPTMAP3K7TAB1KDM4E
SCHEMBL659270 0.67 MAP3K7 (0.47) TLR8MAPTMAP3K7TAB1KDM4E
SCHEMBL659979 0.66 TLR8 (0.40) TLR8MAPTMAP3K7TAB1
SCHEMBL664646 0.65 MAP3K7 (0.64) TLR8MAP3K7TAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
EP-2534156-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2012-12-19 EP disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed
WO-2011100502-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI Pharmaceuticals, LLC (US) 2011-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 QPCT 3044/4885QPCTL 3785/4885TLR8 2644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.